{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30303002", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "23"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1021/acs.jnatprod.8b00733"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "81", "Issue": "10", "PubDate": {"Year": "2018", "Month": "Oct", "Day": "26"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Ancistrolikokine E<sub>3</sub>, a 5,8'-Coupled Naphthylisoquinoline Alkaloid, Eliminates the Tolerance of Cancer Cells to Nutrition Starvation by Inhibition of the Akt/mTOR/Autophagy Signaling Pathway.", "Pagination": {"StartPage": "2282", "EndPage": "2291", "MedlinePgn": "2282-2291"}, "Abstract": {"AbstractText": ["PANC-1 human pancreatic cancer cells are characterized by their ability to proliferate aggressively under hypovascular and hypoxic conditions in the tumor microenvironment, displaying a remarkable tolerance to nutrition starvation. The antiausterity strategy is a new approach in anticancer drug discovery aiming at the identification of potent agents that inhibit preferentially the survival of tumor cells during a limited supply of nutrients and oxygen. The new 5,8'-coupled naphthyldihydroisoquinoline alkaloid ancistrolikokine E<sub>3</sub> (4), isolated from the Congolese liana Ancistrocladus likoko, showed potent preferential cytotoxicity against PANC-1 cells under nutrient-deprived conditions, with a PC<sub>50</sub> value of 2.5 \u03bcM, without exhibiting toxicity in normal, nutrient-rich medium. The compound was found to induce dramatic alterations in cell morphology, leading to cell death. Moreover, it inhibited significantly PANC-1 cell migration and colony formation in a concentration-dependent manner. This study on 4 provides the first live evidence of the effect of a naphthyldihydroisoquinoline alkaloid against PANC-1 cells in nutrient-deprived medium. Mechanistic investigations conducted suggest that compound 4 is a potent inhibitor of the activation of the Akt/mTOR pathway. Furthermore, it inhibited the expression levels of the key autophagy regulators Atg5, Atg12, Beclin-1, LC3-I, and LC3-II. The results demonstrated that ancistrolikokine E<sub>3</sub> (4) is a potent early-stage inhibitor of the autophagy pathway in PANC-1 human pancreatic cancer cells. Ancistrolikokine E<sub>3</sub> (4) and related naphthylisoquinoline alkaloids are promising potential lead compounds for anticancer drug development based on the antiausterity strategy."]}, "AuthorList": [{"Identifier": ["0000-0002-5299-193X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Natural Drug Discovery, Institute of Natural Medicine , University of Toyama , 2630 Sugitani , Toyama 930-0194 , Japan."}], "LastName": "Awale", "ForeName": "Suresh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Natural Drug Discovery, Institute of Natural Medicine , University of Toyama , 2630 Sugitani , Toyama 930-0194 , Japan."}], "LastName": "Dibwe", "ForeName": "Dya Fita", "Initials": "DF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Natural Drug Discovery, Institute of Natural Medicine , University of Toyama , 2630 Sugitani , Toyama 930-0194 , Japan."}], "LastName": "Balachandran", "ForeName": "Chandrasekar", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Organic Chemistry , University of W\u00fcrzburg , Am Hubland, D-97074 W\u00fcrzburg , Germany."}], "LastName": "Fayez", "ForeName": "Shaimaa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Organic Chemistry , University of W\u00fcrzburg , Am Hubland, D-97074 W\u00fcrzburg , Germany."}], "LastName": "Feineis", "ForeName": "Doris", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Organic Chemistry , University of W\u00fcrzburg , Am Hubland, D-97074 W\u00fcrzburg , Germany."}, {"Identifier": [], "Affiliation": "Facult\u00e9 des Sciences , Universit\u00e9 de Kinshasa , B.P. 202, Kinshasa XI , Democratic Republic of the Congo."}], "LastName": "Lombe", "ForeName": "Blaise Kimbadi", "Initials": "BK"}, {"Identifier": ["0000-0002-3583-5935"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Organic Chemistry , University of W\u00fcrzburg , Am Hubland, D-97074 W\u00fcrzburg , Germany."}], "LastName": "Bringmann", "ForeName": "Gerhard", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoquinolines"}, {"RegistryNumber": "EC 2.7.1.1", "NameOfSubstance": "MTOR protein, human"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Oncogene Protein v-akt"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Autophagy"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Congo"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Isoquinolines"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oncogene Protein v-akt"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Pancreatic Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": [], "DescriptorName": "Tumor Stem Cell Assay"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30303002", "10.1021/acs.jnatprod.8b00733"]}}]}